Vaccine Pipeline Database: 1-Year Subscription

Vaccine Pipeline Database: 1-Year Subscription


October 1, 2011
SKU: LAM6588958
License type:
PDF Email from Publisher - One Year Subscription      US $1,333.00
Global Site License -One Year Subscription      US $3,999.00
Subscription to La Merie’s proprietary Vaccine Pipeline Database provides online access to more than 1,200 project entries for prophylactic and therapeutic vaccines on the market and in research & development. Each project is specified for its Target or Mechanism of Action, Therapeutic Area and R&D Phase. Use of the R&D database of vaccines is intuitive. Data sets of interest can be printed and exported. Projects are being updated continuously. The R&D history of each project with online references of information sources can be viewed and printed. The projects can be segmented into Territories, Therapeutic Areas and R&D Phases. An advanced search function allows to combine search parameters. A scroll down menu for predefined targets conveniently selects projects of interest. By clicking on column heads of the project list, projects can be arranged in ascending or descending alphabetical or numerical order, e.g. for phase, product category or company name. Sample screenshots illustrate the database.

Purchase of the subscription provides a 1-year online access to the data of the Vaccine Pipeline Database. Credentials to access the database will be sent by e-mail within 24 hours after purchase.

Benefits from the Vaccine Pipeline Database:
  • New database (since 2008) with no historical burden
  • Intuitive use
  • Designed for structured searches
  • Focused on targets, therapeutic areas and R&D phases
  • Ideal for competitor analysis (companies, targets, product categories)
  • Cost-effective and rapid solution for benchmarking
  • Identification of licensing candidates
Project listing in a tabular format:
  • Drug Codes
  • Target / Mechanism of Action
  • Class of Compound
  • Product Category
  • Company
  • Territory
  • Therapeutic Area
  • Indication
  • R&D Phase
Therapeutic Areas:
  • Cardiovascular & blood
  • Dermatology
  • Gastrointestinal
  • Genitourinary, renal & gynecology
  • Infectious & toxicology
  • Metabolism & endocrine
  • Neurology & psychiatry
  • Oncology
  • Ophthalmology & otorhinolaryngology
  • Orthopedics, dental, anesthesia & surgery
  • Pulmonary & respiratory
  • Rheumatoid & autoimmune
Examples of Predefined Targets of the Scroll Down Menu:
  • Hepatitis Vaccines
  • Influenza Vaccines
  • Herpes Virus Vaccines
  • Staphylococcal Aureus Vaccines
  • Streptococcal Vaccines
  • Pseudomonas Aeruginosa Vaccines
  • Cytomegalovirus (CMV) Vaccines
  • Tuberculosis Vaccines
  • Anthrax Vaccines
  • Respiratory Syncytial Virus (RSV) Vaccines
  • Human Papilloma Virus (HPV) Vaccines
  • Malaria Vaccines
  • Dengue Virus Vaccines
  • Human Immunodeficiency Virus (HIV) Vaccines
  • Therapeutic Cancer Vaccines


Additional Information

About Competitor Analysis Series:

The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.

More Vaccines reports by La Merie Publishing

Competitor Analysis: Cancer Vaccines by La Merie Publishing
Cancer Vaccines The present Competitive Intelligence report about Cancer Vaccines provides a competitor evaluation in the field of novel prophylactic and therapeutic vaccines to ...
Competitor Analysis: Clostridium Difficile Vaccines and Therapeutics by La Merie Publishing
Competitor Analysis: Clostridium Difficile Vaccines and Therapeutics Clostridium difficile infections (CDI) are a major public health concern.  CDI are becoming increasingly prevalent in hospitals, long-term ...
Competitor Analysis: Staphylococcus aureus Vaccines and Therapeutics (Antibodies, Antibiotics, Anti-Infectives) by La Merie Publishing
Competitor Analysis: Staphylococcus aureus Vaccines and Therapeutics (Antibodies, Antibiotics, Anti-Infectives) Novel Prophylactic and Therapeutic Approaches to Manage Staphylococcus aureus (S. aureus) Infections Staphylococcus ...
Competitor Analysis: Smallpox Vaccines & Therapeutics by La Merie Publishing
Competitor Analysis: Smallpox Vaccines & Therapeutics Product description The Competitive Intelligence report Smallpox Vaccines & Therapeutics as of August 2013 provides a competitor analysis ...
See all reports like this >>